CN106822056A - A kind of Oxiracetam oral formulations and preparation method thereof - Google Patents

A kind of Oxiracetam oral formulations and preparation method thereof Download PDF

Info

Publication number
CN106822056A
CN106822056A CN201510903745.3A CN201510903745A CN106822056A CN 106822056 A CN106822056 A CN 106822056A CN 201510903745 A CN201510903745 A CN 201510903745A CN 106822056 A CN106822056 A CN 106822056A
Authority
CN
China
Prior art keywords
parts
oxiracetam
film
viscous fluid
filmogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510903745.3A
Other languages
Chinese (zh)
Inventor
叶雷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Runze Pharmaceutical Co Ltd
Original Assignee
Chongqing Runze Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Runze Pharmaceutical Co Ltd filed Critical Chongqing Runze Pharmaceutical Co Ltd
Priority to CN201510903745.3A priority Critical patent/CN106822056A/en
Publication of CN106822056A publication Critical patent/CN106822056A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Abstract

A kind of Oxiracetam oral formulations and preparation method thereof, are obtained using materials such as composite membrane-forming material, plasticizer, fillers；The present invention is difficult to spue after adhering on the tongue, is adapted to the old man of dysphagia, and by mucosal absorption, it is to avoid first to cross elimination effect, improves bioavilability, pharmaceutical dosage is reduced, so as to reduce drug side-effect.Preparation process is simple of the present invention, is adapted to industrialized production.

Description

A kind of Oxiracetam oral formulations and preparation method thereof
Technical field
The present invention relates to a kind of Oxiracetam oral formulations and preparation method thereof.
Background technology
Oxiracetam is a kind of hydroxy-amino-butyric acid of synthesis (GABOB) cyclic derivatives, Intracerebral ATP can be promoted, promote acetylcholine to synthesize and strengthen the conduction of nervous excitation, to anoxic Caused antidromicity is forgetful to have improvement to act on, and can strengthen memory, improves learning ability. CN104069074A discloses a kind of Oxiracetam injection lyophilized formulations, and said preparation is first by Austria La Xitan forms the certain density aqueous solution, is subsequently adding methyl alcohol lyophilized prepared；The lyophilized formulations Auxiliary material is substantially free of, redissolution is rapid, quality is good, storage is stable.Such preparation is directly injected into group Knit or blood vessel, it is very short without absorption process or absorption process, thus haemoconcentration can rapidly reach height Peak plays a role；But it is developed and production process is complicated, because injection requirement is aseptic without heat Original, production process is strict, and step is more to need appointed condition higher, and injection Chinese medicine Thing is generally dispersed in water with the micron-sized solid small particles of molecular state, and decentralization is very big, And often to produce drug hydrolysis, oxidation, solids coalescence to become big etc. steady by high-temperature sterilization Qualitative question.Simultaneously because injection directly quickly enters human body, without human body normal physiological barrier Protection, if therefore dosage is improper or inject too fast, or there is problem in drug quality, and having can Harm can be brought to patient, or even cause the consequence that cannot be retrieved.In addition injection pain, can not Scleroma and intravenous injection is produced to cause the vascular inflammation to be all by patient's self-administer, injection site The problem existed during clinical practice.
CN101732251A discloses a kind of oxiracetam liposome, by Oxiracetam, phosphatide, Cholesterol, Tween 80 and appropriate osmotic pressure regulator and cushioning liquid are obtained；The lipid Body good stability, envelop rate are high, toxic and side effect is small；But liposome preparation complex process, no It is adapted to large-scale production；Curative effect of the what is more important liposome in human body need further Study, the current country rarely has Liposomal formulation for clinic.
CN103494790A discloses a kind of oxiracetam capsule, by xylitol, lubricant and The Oxiracetam of crystal form is obtained；Obtained oxiracetam capsule quality stability is significantly carried Height, preparation process is simple, production cost reduction.CN104739796A discloses a kind of Aura Western smooth tablet, by a certain amount of Oxiracetam, filler, disintegrant, binder and lubricant It is obtained；The tablets, carry, and transport and storage are all more convenient.But in actual clinical, Capsule, tablet are choked and cough event often, and the patient of feeblemindedness is in the majority with the elderly, This kind of patient takes oxiracetam capsule agent, tablet very not usually for medicine dysphagia Just.
CN1555794A discloses a kind of Orazitan dispersion tablet, by Oxiracetam disintegrant, profit Lubrication prescription and glidant and adhesive are obtained, and can be promptly disintegrated into after the medicine is oral dispersed Fine particle, is conducive to drug-eluting to absorb；It is convenient to take, it is oral after the dispersion that can add water, also may be used It is contained in mouth and suckes clothes or swallow.Oral dispersable tablet equally exists the problem choked and cough, and suckes clothes Dispersible tablet, it works very slowly, and there is sand type and bitter taste, is unfavorable for taking.
The content of the invention
According to the first aspect of the invention, the present invention provides a kind of Oxiracetam oral formulations, should Preparation is oral quick-dissolving film preparation, can just be dissolved with a small amount of saliva in oral cavity, and it is rapid to work, It is adapted to old people garment to use.
Unless otherwise specified, number of the present invention is weight portion.
The object of the present invention is achieved like this：
Above-mentioned Oxiracetam oral quick-dissolving film preparation is obtained according to the following ratio：
The filmogen is comprising acrylate and at least another macromolecule filming material；Institute State another macromolecule filming material and be selected from hydroxypropyl methyl cellulose, hydroxypropyl cellulose, branch Chain starch, sodium carboxymethylcellulose or pulullan polysaccharide；The plasticizer is selected from phthalic acid In dibutyl ester, glyceryl triacetate, triethyl citrate, Trimethyl citrate or PEG400 One or more combination；The filler is selected from microcrystalline cellulose, low substituted hydroxy-propyl fiber One or more combination in element, pregelatinized starch, Ac-Di-Sol；It is described sweet Taste agent is one or more in acesulfame potassium, sweet Abbas, Sucralose, essence, xylitol Combination.
An embodiment of the invention, above-mentioned Oxiracetam oral quick-dissolving film preparation use with Lower proportioning is obtained：
The filmogen is comprising acrylate and at least another macromolecule filming material；Institute State another macromolecule filming material and be selected from hydroxypropyl methyl cellulose, hydroxypropyl cellulose, branch Chain starch, sodium carboxymethylcellulose, pulullan polysaccharide, wherein hydroxypropyl methyl cellulose, hydroxyl The consumption of propyl cellulose, amylopectin, sodium carboxymethylcellulose or pulullan polysaccharide is respectively： 3 parts~35 parts, 8~16 parts, 5~10 parts, 1~5 part, 12~18 parts.
An embodiment of the invention, above-mentioned Oxiracetam oral quick-dissolving film preparation use with Lower proportioning is obtained：
The filmogen is that acrylate and hydroxypropyl methyl cellulose are combined, wherein hydroxyl Third methylcellulose consumption is 10 parts~30 parts；The filler is microcrystalline cellulose or low takes For hydroxypropyl cellulose；The plasticizer be dibutyl phthalate, glyceryl triacetate or One kind in Trimethyl citrate；The sweetener be acesulfame potassium, sweet Abbas, Sucralose, Essence or xylitol.
An embodiment of the invention, above-mentioned Oxiracetam oral quick-dissolving film preparation use with Lower proportioning is obtained：
The filmogen is that acrylate and hydroxypropyl cellulose are constituted, wherein hydroxy propyl cellulose Plain consumption is 11 parts~15 parts；The filler is low-substituted hydroxypropyl cellulose or pregelatinated Starch；The plasticizer is glyceryl triacetate or glyceryl triacetate；The sweetener is peace Match honey, sweet Abbas, Sucralose, essence or xylitol.
An embodiment of the invention, above-mentioned Oxiracetam oral quick-dissolving film preparation use with Lower proportioning is obtained：
The filmogen is that acrylate and hydroxypropyl cellulose are constituted, wherein hydroxy propyl cellulose Plain consumption is 11 parts~15 parts；The filler is low-substituted hydroxypropyl cellulose or pregelatinated Starch；The plasticizer is glyceryl triacetate or glyceryl triacetate；The sweetener is peace Match honey, sweet Abbas, Sucralose, essence or xylitol.
An embodiment of the invention, above-mentioned Oxiracetam oral quick-dissolving film preparation use with Lower proportioning is obtained：
The filmogen is that acrylate and hydroxypropyl methyl cellulose are constituted, wherein hydroxypropyl first Base cellulose consumption is 5 parts~20 parts；The filler is microcrystalline cellulose or crosslinking carboxylic first Base sodium cellulosate；The plasticizer is the one kind in glyceryl triacetate or Trimethyl citrate； The sweetener is acesulfame potassium, sweet Abbas, Sucralose, essence or xylitol.
An embodiment of the invention, above-mentioned Oxiracetam oral quick-dissolving film preparation use with Lower proportioning is obtained：
The filmogen is acrylate, amylopectin and pulullan polysaccharide composition, wherein propping up Chain starch consumption is 5 parts~10 parts, and pulullan polysaccharide consumption is 15~18 parts；The filling Agent is microcrystalline cellulose or pregelatinized starch；The plasticizer is triethyl citrate or triacetic acid Glyceride；The sweetener is acesulfame potassium, sweet Abbas, Sucralose, essence or xylitol.
An embodiment of the invention, above-mentioned Oxiracetam oral quick-dissolving film preparation use with Lower proportioning is obtained：
The filmogen is acrylate, hydroxypropyl cellulose and amylopectin composition, wherein Hydroxypropyl cellulose consumption is 12 parts~15 parts, and amylopectin consumption is 5 parts~10 parts；Institute Filler is stated for pregelatinized starch or Ac-Di-Sol；The plasticizer is adjacent benzene two Formic acid dibutyl ester or triethyl citrate；The sweetener is acesulfame potassium, Abbas is sweet, trichlorine Sucrose, essence or xylitol.
According to the second aspect of the invention, the present invention provides above-mentioned Oxiracetam oral quick-dissolving film preparation Preparation method, using following steps：
1) by filmogen deionized water dissolving, slough bubble and uniform viscous fluid is obtained；
2) plasticizer, filler and sweetener deionized water are uniformly dispersed into dispersion liquid；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add Aura It is western it is smooth be uniformly dispersed, then stand slough bubble；
4) will remove bubble after viscous fluid with medicine film coating dryer be coated with, dry, peel off, Cutting is obtained final product.
Above-mentioned steps 1), step 2) in deionized water consumption according to actual conditions by ability Domain those of ordinary skill determines.
Inventor has found that the Oxiracetam oral quick-dissolving film preparation of preparation is being peeled off in R＆D process During easily occur coming off, and have during cutting fracture phenomena occurs.
An embodiment of the invention, the coating speed of above-mentioned medicine film drying machine is 68-84cm/min, drying temperature is 72-80 DEG C.
Take into account disintegration time limited and patient adaptability, the thickness of Oxiracetam film of the present invention with 95~ 110 μm are advisable.
An embodiment of the invention,
A kind of preparation method of Oxiracetam film, using following steps：
1) by 45-60 parts of filmogen (acrylate and hydroxypropyl methyl cellulose are constituted, Wherein HPMC consumption is 10 parts~30 parts) deionized water dissolving is used, slough bubble Uniform viscous fluid is obtained；
2) by 10-18 parts of plasticizer (dibutyl phthalate, glyceryl triacetate or Trimethyl citrate), (microcrystalline cellulose or low substituted hydroxy-propyl are fine for 15-20 parts of filler Dimension element) and 1-5 parts of sweetener (acesulfame potassium, sweet Abbas, Sucralose, essence or xylose Alcohol) it is uniformly dispersed into dispersion liquid with deionized water；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 5-20 The Oxiracetam of part is uniformly dispersed, and then stands and sloughs bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 50-80cm/min, then with 65-85 DEG C of drying, stripping, cutting are obtained final product.
An embodiment of the invention,
A kind of preparation method of Oxiracetam film, using following steps：
1) by 44-55 parts of filmogen (acrylate and hydroxypropyl cellulose are constituted, wherein Hydroxypropyl cellulose consumption is 11 parts~15 parts) deionized water dissolving is used, slough bubble and be obtained Even viscous fluid；
2) by 10-15 parts of plasticizer (glyceryl triacetate or glyceryl triacetate), 15-20 Part filler (low-substituted hydroxypropyl cellulose or pregelatinized starch) and 1-5 parts (acesulfame potassium, Abbas is sweet, Sucralose, essence or xylitol) be uniformly dispersed into dispersion liquid with deionized water；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 8-18 The Oxiracetam of part is uniformly dispersed, and then stands and sloughs bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 60-80cm/min, then with 70-82 DEG C of drying, stripping, cutting are obtained final product.
An embodiment of the invention,
A kind of preparation method of Oxiracetam film, using following steps：
1) by 50-62 parts of filmogen, (acrylate and amylopectin are constituted, wherein side chain Starch consumption is 8 parts~15 parts) deionized water dissolving is used, slough bubble prepared uniform sticky Liquid；
2) by 10-20 parts of plasticizer (dibutyl phthalate or glyceryl triacetate), 15-30 parts of filler (low-substituted hydroxypropyl cellulose or Ac-Di-Sol) and 1-5 parts (acesulfame potassium, sweet Abbas, Sucralose, essence or xylitol) uses deionized water It is uniformly dispersed into dispersion liquid；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 8-20 The Oxiracetam of part is uniformly dispersed, and then stands and sloughs bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 60-78cm/min, then with 70-85 DEG C of drying, stripping, cutting are obtained final product.
An embodiment of the invention,
A kind of preparation method of Oxiracetam film, using following steps：
1) by 50-60 parts of filmogen (acrylate and hydroxypropyl methyl cellulose are constituted, Wherein HPMC consumption is 5 parts~20 parts) deionized water dissolving is used, slough bubble Uniform viscous fluid is obtained；
2) by 10-20 parts of plasticizer (glyceryl triacetate or Trimethyl citrate), 10-25 Part filler (microcrystalline cellulose or Ac-Di-Sol) and 1-5 parts (acesulfame potassium, Abbas is sweet, Sucralose, essence or xylitol) be uniformly dispersed into dispersion liquid with deionized water；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 5-15 The Oxiracetam of part is uniformly dispersed, and then stands and sloughs bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 60-75cm/min, then with 70-85 DEG C of drying, stripping, cutting are obtained final product.
An embodiment of the invention,
A kind of preparation method of Oxiracetam film, using following steps：
1) by 45-60 parts of filmogen (acrylate, amylopectin and pulullan polysaccharide group Into wherein amylopectin consumption is 5 parts~10 parts, and pulullan polysaccharide consumption is 15~18 parts) With deionized water dissolving, slough bubble and uniform viscous fluid is obtained；
2) by 10-20 parts of plasticizer (triethyl citrate or glyceryl triacetate), 15-25 The filler (microcrystalline cellulose or pregelatinized starch) of part and 1-5 parts of (acesulfame potassium, Abbas Sweet, Sucralose, essence or xylitol) it is uniformly dispersed into dispersion liquid with deionized water；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 6-15 The Oxiracetam of part is uniformly dispersed, and then stands and sloughs bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 50-80cm/min, then with 65-85 DEG C of drying, stripping, cutting are obtained final product.
An embodiment of the invention,
A kind of preparation method of Oxiracetam film, using following steps：
1) by 45-60 parts of filmogen (acrylate, hydroxypropyl cellulose and amylopectin Composition, wherein hydroxypropyl cellulose consumption be 12 parts~15 parts, amylopectin consumption be 5 parts~ 10 parts) deionized water dissolving is used, slough bubble and uniform viscous fluid is obtained；
2) by 10-20 parts of plasticizer (dibutyl phthalate or triethyl citrate), 15-25 parts of filler (pregelatinized starch or Ac-Di-Sol) and 1-5 parts of (peace Match honey, sweet Abbas, Sucralose, essence or xylitol) it is uniformly dispersed into deionized water Dispersion liquid；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 5-20 The Oxiracetam of part is uniformly dispersed, and then stands and sloughs bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 50-80cm/min, then with 65-85 DEG C of drying, stripping, cutting are obtained final product.
The invention has the advantages that：
Oxiracetam oral quick-dissolving film preparation prepared by the present invention, it is with a small amount of saliva in oral cavity Can dissolve, medication by being not required to water delivery service, medication is convenient；And be difficult to tell after being adhered on tongue Go out, be adapted to the patient of dysphagia, and by mucosal absorption, it is to avoid be first to cross elimination effect, Bioavilability is improve, pharmaceutical dosage is reduced, so as to reduce drug side-effect.
The present invention prepares Oxiracetam film using medicine film film applicator, and strictly controls the thickness of film Degree, coating speed and drying temperature, so as to effectively solve and cut easy to fall off and cut The technical problem such as broken, it is ensured that the quality of product so that when fragility of the invention, disintegration The aspect such as limit and solution time is more conducive to clinical practice.
The present invention specific material proportion of selection, and the acrylate of selection specified quantitative and extremely meticulously Few another kind macromolecular material (hydroxypropyl methyl cellulose, hydroxypropyl cellulose, amylopectin, Sodium carboxymethylcellulose or pulullan polysaccharide) compound film material is formed, so as to solve Oxiracetam Film easily occurs that matter is soft, filming performance is poor, be difficult to the technical problems such as the demoulding, improves product Quality.Preparation method of the present invention is simple, it is not necessary to large industry equipment, is adapted to industrialized production.
Embodiment
In order that the purpose of the present invention and technical scheme are clearer, below to of the invention preferred Embodiment is described in detail.To illustrate that：Following examples are served only for entering the present invention Row further instruction, and it is not intended that limiting the scope of the invention.This area Some nonessential modifications and adaptations that technical staff's the above of the invention is made are equal Belong to protection scope of the present invention.
Embodiment 1
The preparation of Oxiracetam film, using following steps：
1) by 58g filmogens, (acrylate and hydroxypropyl methyl cellulose are constituted, wherein hydroxyl Third methylcellulose consumption is 30g) 80mL deionized water dissolvings are used, slough bubble and be obtained uniformly Viscous fluid；
2) by 18g dibutyl phthalates, 15g microcrystalline celluloses and 2g xylitols 50mL Deionized water is uniformly dispersed into dispersion liquid；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 7g Oxiracetam is uniformly dispersed, and then stands and sloughs bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 50cm/min, then with 65-68 DEG C of drying, stripping, cutting are obtained final product.
Embodiment 2
The preparation of Oxiracetam film, using following steps：
1) by the filmogen of 50g (acrylate and hydroxypropyl methyl cellulose are constituted, wherein HPMC consumption is 10g) 50mL deionized water dissolvings are used, slough bubble and be obtained Even viscous fluid；
2) by 12g glyceryl triacetates, 20g low-substituted hydroxypropyl celluloses and 1g acesulfame potassiums Dispersion liquid is uniformly dispersed into 60mL deionized waters；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 17g Oxiracetam be uniformly dispersed, then stand slough bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 80cm/min, then with 70-72 DEG C of drying, stripping, cutting are obtained final product.
Embodiment 3
The preparation of Oxiracetam film, using following steps：
1) by the filmogen of 50g (acrylate and hydroxypropyl methyl cellulose are constituted, wherein HPMC consumption is 20g) 50mL deionized water dissolvings are used, slough bubble and be obtained Even viscous fluid；
2) by 15g Trimethyl citrates, 15g microcrystalline celluloses and 5g Abbas is sweet uses 40mL Deionized water is uniformly dispersed into dispersion liquid；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 15g Oxiracetam be uniformly dispersed, then stand slough bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 70cm/min, then with 80-85 DEG C of drying, stripping, cutting are obtained final product.
Embodiment 4
The preparation of Oxiracetam film, using following steps：
1) by the filmogen of 51g, (acrylate and hydroxypropyl cellulose are constituted, wherein hydroxypropyl Base cellulose consumption is 15g) 80mL deionized water dissolvings are used, slough bubble and uniform gluing is obtained Magma；
2) by 12g glyceryl triacetates, 15g low-substituted hydroxypropyl celluloses and 4g trichlorine sugarcanes Sugar is uniformly dispersed into dispersion liquid with 30mL deionized waters；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 18g Oxiracetam is uniformly dispersed, and then stands and sloughs bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 65cm/min, then with 70-72 DEG C of drying, stripping, cutting are obtained final product.
Embodiment 5
The preparation of Oxiracetam film, using following steps：
1) by the filmogen of 50g, (acrylate and hydroxypropyl cellulose, wherein hydroxypropyl are fine The plain consumption of dimension is 11g) deionized water dissolving is used, slough bubble and uniform viscous fluid is obtained；
2) 15g glyceryl triacetates, 22g pregelatinized starch and 3g xylitols 60mL are used Deionized water is uniformly dispersed into dispersion liquid；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 10g Oxiracetam be uniformly dispersed, then stand slough bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 70cm/min, then with 75-78 DEG C of drying, stripping, cutting are obtained final product.
Embodiment 6
The preparation of Oxiracetam film, using following steps：
1) by the filmogen of 48g, (acrylate and hydroxypropyl cellulose are constituted, wherein hydroxypropyl Base cellulose consumption is 12g) 55mL deionized water dissolvings are used, slough bubble and uniform gluing is obtained Magma；
2) by 15g glyceryl triacetates, 19g pregelatinized starch and 1g Abbas is sweet uses 45mL Deionized water is uniformly dispersed into dispersion liquid；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 17g Oxiracetam be uniformly dispersed, then stand slough bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 80cm/min, then with 80-82 DEG C of drying, stripping, cutting are obtained final product.
Embodiment 7
The preparation of Oxiracetam film, using following steps：
1) by the filmogen of 60g, (acrylate and amylopectin are constituted, wherein amylopectin Consumption is 10g) 80mL deionized water dissolvings are used, slough bubble and uniform viscous fluid is obtained；
2) by 15g dibutyl phthalates, 15g low-substituted hydroxypropyl celluloses and 2g wood Sugar alcohol is uniformly dispersed into dispersion liquid with 30mL deionized waters；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 8g Oxiracetam be uniformly dispersed, then stand slough bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 65cm/min, then with 75-78 DEG C of drying, stripping, cutting are obtained final product.
Embodiment 8
The preparation of Oxiracetam film, using following steps：
1) by the filmogen of 50g, (acrylate and amylopectin are constituted, wherein amylopectin Consumption is 8g) 65mL deionized water dissolvings are used, slough bubble and uniform viscous fluid is obtained；
2) 20g glyceryl triacetates, 20g connection sodium carboxymethylcelluloses and 2g acesulfame potassiums are used 50mL deionized waters are uniformly dispersed into dispersion liquid；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 8g Oxiracetam be uniformly dispersed, then stand slough bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 70cm/min, then with 70-72 DEG C of drying, stripping, cutting are obtained final product.
Embodiment 9
The preparation of Oxiracetam film, using following steps：
1) by the filmogen of 52g, (acrylate and amylopectin are constituted, wherein amylopectin Consumption is 5g) 65mL deionized water dissolvings are used, slough bubble and uniform viscous fluid is obtained；
2) it is 10g dibutyl phthalates, 22g low-substituted hydroxypropyl celluloses and 3g is fragrant Essence is uniformly dispersed into dispersion liquid with 35mL deionized waters；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 13g Oxiracetam be uniformly dispersed, then stand slough bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 78cm/min, then with 82-85 DEG C of drying, stripping, cutting are obtained final product.
Embodiment 10
The preparation of Oxiracetam film, using following steps：
1) by the filmogen of 50g (acrylate and hydroxypropyl methyl cellulose are constituted, wherein HPMC consumption is 5g) 50mL deionized water dissolvings are used, slough bubble and be obtained Even viscous fluid；
2) 15g glyceryl triacetates, 24g microcrystalline celluloses and 1g essence are gone with 50mL Ionized water is uniformly dispersed into dispersion liquid；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 10g Oxiracetam be uniformly dispersed, then stand slough bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 60cm/min, then with 82-85 DEG C of drying, stripping, cutting are obtained final product.
Embodiment 11
The preparation of Oxiracetam film, using following steps：
1) by the filmogen of 60g (acrylate and hydroxypropyl methyl cellulose are constituted, wherein HPMC consumption is 20g) 80mL deionized water dissolvings are used, slough bubble and be obtained Even viscous fluid；
2) by 10g Trimethyl citrates, 16g Ac-Di-Sols and 2g Abbas Sweet 20mL deionized waters are uniformly dispersed into dispersion liquid；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 12g Oxiracetam be uniformly dispersed, then stand slough bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 75cm/min, then with 70-72 DEG C of drying, stripping, cutting are obtained final product.
Embodiment 12
The preparation of Oxiracetam film, using following steps：
1) by the filmogen of 57g (acrylate and hydroxypropyl methyl cellulose are constituted, wherein HPMC consumption is 10g) 65mL deionized water dissolvings are used, slough bubble and be obtained Even viscous fluid；
2) by 15g glyceryl triacetates, 20g microcrystalline celluloses and 3g xylitols 40mL Deionized water is uniformly dispersed into dispersion liquid；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 5g Oxiracetam is uniformly dispersed, and then stands and sloughs bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 70cm/min, then with 75-78 DEG C of drying, stripping, cutting are obtained final product.
Embodiment 13
The preparation of Oxiracetam film, using following steps：
1) by the filmogen of 45g (acrylate, amylopectin and pulullan polysaccharide composition, Wherein amylopectin consumption is 6g, and pulullan polysaccharide consumption is 15g) use 50mL deionized waters Dissolving, sloughs bubble and uniform viscous fluid is obtained；
2) by 15g triethyl citrates, 25g microcrystalline celluloses and 3g xylitols 50mL Deionized water is uniformly dispersed into dispersion liquid；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 12g Oxiracetam be uniformly dispersed, then stand slough bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 80cm/min, then with 82-85 DEG C of drying, stripping, cutting are obtained final product.
Embodiment 14
The preparation of Oxiracetam film, using following steps：
1) by the filmogen of 55g (acrylate, amylopectin and pulullan polysaccharide composition, Wherein amylopectin consumption is 10g, and pulullan polysaccharide consumption is 18g) use 70mL deionized waters Dissolving, sloughs bubble and uniform viscous fluid is obtained；
2) by 19g glyceryl triacetates, 19g pregelatinized starch and 1g Abbas is sweet uses 30mL Deionized water is uniformly dispersed into dispersion liquid；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 6g Oxiracetam be uniformly dispersed, then stand slough bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 50cm/min, then with 65-68 DEG C of drying, stripping, cutting are obtained final product.
Embodiment 15
The preparation of Oxiracetam film, using following steps：
1) by the filmogen of 45g (acrylate, amylopectin and pulullan polysaccharide composition, Wherein amylopectin consumption is 8g, and pulullan polysaccharide consumption is 16g) use 50mL deionized waters Dissolving, sloughs bubble and uniform viscous fluid is obtained；
2) by 15g triethyl citrates, 23g pregelatinized starch and 2g xylitols 50mL Deionized water is uniformly dispersed into dispersion liquid；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 15g Oxiracetam be uniformly dispersed, then stand slough bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 70cm/min, then with 73-75 DEG C of drying, stripping, cutting are obtained final product.
Embodiment 16
The preparation of Oxiracetam film, using following steps：
1) by the filmogen of 45g (acrylate, hydroxypropyl cellulose and amylopectin composition, Wherein hydroxypropyl cellulose consumption is 12g, and amylopectin consumption is 5g) use 50mL deionizations Water dissolves, slough bubble and uniform viscous fluid are obtained；
2) by 15g triethyl citrates, 24g Ac-Di-Sols and 1g Abbas Sweet 30mL deionized waters are uniformly dispersed into dispersion liquid；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 15g Oxiracetam be uniformly dispersed, then stand slough bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 50cm/min, then with 65-67 DEG C of drying, stripping, cutting are obtained final product.
Embodiment 17
The preparation of Oxiracetam film, using following steps：
1) by the filmogen of 59g (acrylate, hydroxypropyl cellulose and amylopectin composition, Wherein hydroxypropyl cellulose consumption is 15g, and amylopectin consumption is 10g) use 70mL deionizations Water dissolves, slough bubble and uniform viscous fluid are obtained；
2) by 15g dibutyl phthalates, 15g pregelatinized starch and 1g essence 30mL Deionized water is uniformly dispersed into dispersion liquid；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 10g Oxiracetam be uniformly dispersed, then stand slough bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 80cm/min, then with 83-85 DEG C of drying, stripping, cutting are obtained final product.
Embodiment 18
The preparation of Oxiracetam film, using following steps：
1) by the filmogen of 50g (acrylate, hydroxypropyl cellulose and amylopectin composition, Wherein hydroxypropyl cellulose consumption is 13g, and amylopectin consumption is 7g) use 55mL deionizations Water dissolves, slough bubble and uniform viscous fluid are obtained；
2) by 15g dibutyl phthalates, 18g Ac-Di-Sols and 2g Ahs This Ba Tian is uniformly dispersed into dispersion liquid with 45mL deionized waters；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 15g Oxiracetam be uniformly dispersed, then stand slough bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 70cm/min, then with 75-78 DEG C of drying, stripping, cutting are obtained final product.
Embodiment 19
The preparation of Oxiracetam film, using following steps：
1) by the acrylate of 50g 55mL deionized water dissolvings, slough bubble and be obtained Even viscous fluid；
2) by 15g dibutyl phthalates, 18g Ac-Di-Sols and 2g Ahs This Ba Tian is uniformly dispersed into dispersion liquid with 45mL deionized waters；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 15g Oxiracetam be uniformly dispersed, then stand slough bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 70cm/min, then with 75-78 DEG C of drying, stripping, cutting are obtained final product.
Embodiment 20
The preparation of Oxiracetam film, using following steps：
1) by the filmogen of 50g, (HPMC, hydroxypropyl cellulose and side chain form sediment Powder is constituted, wherein HPMC 30g, and hydroxypropyl cellulose consumption is 13g, side chain Starch consumption is 7g) 55mL deionized water dissolvings are used, slough bubble and uniform viscous fluid is obtained；
2) by 15g dibutyl phthalates, 18g Ac-Di-Sols and 2g Ahs This Ba Tian is uniformly dispersed into dispersion liquid with 45mL deionized waters；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 15g Oxiracetam be uniformly dispersed, then stand slough bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 70cm/min, then with 75-78 DEG C of drying, stripping, cutting are obtained final product.
Embodiment 21
The preparation of Oxiracetam film, using following steps：
1) by the filmogen of 50g (acrylate, hydroxypropyl cellulose and amylopectin composition, Wherein hydroxypropyl cellulose consumption is 13g, and amylopectin consumption is 7g) use 55mL deionizations Water dissolves, slough bubble and uniform viscous fluid are obtained；
2) by 15g dibutyl phthalates, 18g Ac-Di-Sols and 2g Ahs This Ba Tian is uniformly dispersed into dispersion liquid with 45mL deionized waters；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 15g Oxiracetam be uniformly dispersed, then stand slough bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 20cm/min, then with 75-78 DEG C of drying, stripping, cutting are obtained final product.
Embodiment 22
The preparation of Oxiracetam film, using following steps：
1) by the filmogen of 50g, (HPMC, hydroxypropyl cellulose and side chain form sediment Powder is constituted, wherein HPMC 30g, and hydroxypropyl cellulose consumption is 13g, side chain Starch consumption is 7g) 55mL deionized water dissolvings are used, slough bubble and uniform viscous fluid is obtained；
2) by 15g dibutyl phthalates, 18g Ac-Di-Sols and 2g Ahs This Ba Tian is uniformly dispersed into dispersion liquid with 45mL deionized waters；
3) by step 2) dispersion liquid be added to step 1) viscous fluid in, and add 15g Oxiracetam be uniformly dispersed, then stand slough bubble；
4) viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 70cm/min, then with 50 DEG C of dryings, stripping, cutting are obtained final product.
Embodiment 23
Oxiracetam film obtained in embodiment 1-22 is evaluated, including outward appearance, thickness, The evaluation of ifs vitro disintegration, mechanical properties.
Evaluation method
Ocular estimate：Whether observation membrane surface is complete bright and clean, and whether thickness is consistent, and color and luster is It is no it is uniform, whether there is obvious bubble.
Thickness measurement：Use resolution ratio carries out thickness for the digimatic micrometer of 0.001mm to film Degree measurement, is determined 3 times respectively in every piece of the 3 of film different parts, and record data is obtained Average thickness.
Ifs vitro disintegration time study：The disintegrating property of film is investigated by the disintegration time for determining film And solvability.Magnetic stirring apparatus is placed in the beaker that 50mL distilled water is added 100mL On, be clipped in for test film water-bath be put on clip by 37 DEG C of waters bath with thermostatic control, rotating speed 100r/min Middle beginning timing, the time of record film dissolving.In this experiment, every piece of film is cut out at random 3 block sizes are cut for 1 × 1cm2Membranelle determine, using three average values of measurement result as survey Amount result.
Mechanical performance is evaluated：
This experiment has used the universal testing machine of model 3365 to carry out the mechanical performance of film Evaluate.It is 2 × 0.5cm by size2Film be put between two clips at a distance of 5cm. Draw vice is with the speed membrane of 10mm/min.The elastic modelling quantity (EM) of film, refers to become in elasticity In the shape stage, the ratio of applied stress and adaptability to changes, it is possible to use formula below is calculated：
Elastic modelling quantity=applied stress/adaptability to changes/area of section.
The tensile strength (TS) of film is also strength degree, refers to that material bears maximum before breaking Stress value, computing formula is：
Tensile strength=applied stress/cross-sectional area.
The percent elongation (E%) of film is calculated by following formula：
Percent elongation=length incrementss/the original length × 100.
The Oxiracetam film the performance test results such as following table of embodiment 1-5：
Note：1)The n=10 of the n=6 of thickness, quality and mechanical performance, content and uniformity of dosage units
Experiment display above, the Oxiracetam membrane surface prepared by embodiment 1-5 is smooth, and thickness is equal Even property preferably, possesses suitable suppleness and tensile property, and conveniently stripped, disintegration time does not surpass Cross 21s.
The test result of the Oxiracetam film of embodiment 6-15 is as follows：
Note：1)The n=10 of the n=6 of thickness, quality and mechanical performance, content and uniformity of dosage units
Experiment display above, the Oxiracetam membrane surface prepared by embodiment 6-10 is smooth, thickness Uniformity preferably, possesses suitable suppleness and tensile property, and conveniently stripped, disintegration time is not More than 21s.
The test result of the Oxiracetam film of embodiment 11-15 is as follows：
Note：1)The n=10 of the n=6 of thickness, quality and mechanical performance, content and uniformity of dosage units
Experiment display above, the Oxiracetam membrane surface prepared by embodiment 11-15 is smooth, thickness Uniformity preferably, possesses suitable suppleness and tensile property, and conveniently stripped, disintegration time is not More than 21s.
The test result of the Oxiracetam film of embodiment 16-22 is as follows：
Note：1)The n=10 of the n=6 of thickness, quality and mechanical performance, content and uniformity of dosage units
Experiment display above, the Oxiracetam membrane surface prepared by embodiment 16-18 is smooth, Thickness evenness preferably, possesses suitable suppleness and tensile property, conveniently stripped, during disintegration Between in 20s or so, no more than 22s；The membrane surface of embodiment 19 has projection, the demoulding It is more difficult, and disintegration time limited also relative extension；The surface of embodiment 20 is smooth, toughness Preferably, the also easy demoulding, but disintegration time is slightly long；The membrane surface of embodiment 21 has convex Rise, the demoulding is also more difficult, and disintegration time limited also relative extension；The film of embodiment 22 It is partially wet, there is adhesion phenomenon, disintegration time is slightly long.
Embodiment 19 and embodiment 20 have investigated filmogen to influence of the invention, alone Acrylate is used as filmogen, and disintegration time is slightly long, there is the slightly poor situation of film forming, Demoulding difficulty (embodiment 19) can be caused；Prepared by without acrylate film, film forming Better performances, the easy demoulding, but disintegration time is (embodiment 20) more long.Embodiment 21 The influence of coating speed and drying temperature to film in film-forming process has been investigated with embodiment 22, Wherein coating speed is too fast can cause partially wet, there is adhesion phenomenon；Coating speed can cause film slowly excessively Agent overdrying, so that film is more crisp.Drying temperature can equally influence the brittleness and humidity of film. Oxiracetam film obtained in embodiment 1-22 is carried out into dissolution in vitro experiment, is as a result shown： The Oxiracetam film of embodiment 1-18 starts disintegration in 10s, and drug release is rapid, 5min Interior dissolution is complete more than the basic dissolutions of 90%, 10min；Aura obtained in embodiment 19-22 Starts disintegration in western smooth film 10s, drug release is more rapid, in 5min dissolution more than 70%, Dissolution is complete more than the basic dissolutions of 90%, 20min in 10min.
The embodiment of the present invention is raw materials used to be commercially available prod with reagent.Wherein Oxiracetam raw material (content 99.8%, Chongqing Dongze Pharmaceutical Technology Development Co., Ltd. provides, and lot number is： 20141014)；Hydroxypropyl methylcellulose (HPMC, Dow Chemical company, specification E50)； Hydroxypropylcellulose (HPC, Ashland companies of the U.S., specification LF)；Polyvinyl alcohol (PVA, Aladdin industrial group of the U.S., specification 1788)；Acrylic resin (E100, German rom Company)；Polyethylene glycol (PEG) 400 (Hunan Hua pharmaceutical Co. Ltds)；Triacetic acid is sweet Grease (Hu'nan Erkang Pharmaceutical Co., Ltd.)；Trimethyl citrate (the rich former medicine in Bangbu Development in science and technology Co., Ltd)；Low-substituted hydroxypropyl cellulose (L-HPC), pregelatinized starch (Anhui Shanhe Medicinal Subsidiary Material Co., Ltd.)；Microcrystalline cellulose (MCC, German JRS Company, specification VIVAPUR 101)；Acetonitrile, methyl alcohol are chromatographically pure, and other reagents are analysis It is pure.
Medicine film coating dryer used of the invention is commercially available prod, it is also possible to reference to CN 201668734 U make by oneself, and medicine film coating dryer is by main box, auxiliary box body, peristaltic pump, flat Plate scraper, master roller, deputy roller cylinder, conveyer belt, heating electroplax, induced-draught fan and rolling-up mechanism group Into.Its action principle is added on a moving belt for drug slurry by peristaltic pump, and conveyer belt is in motor Under drive, around main box operating, the liquid on conveyer belt is hung into film by flat scraper, plus Thermoelectric plate air is heated, and induced-draught fan takes the air in main box away, makes air in main box Interior flowing, the solvent of liquid is flung to, drying and moulding, and rolling-up mechanism collects the medicine film of shaping.
To sum up, Oxiracetam film appearance uniform of the present invention is complete, uniform color, and thickness is consistent, Physics and stable chemical nature, disintegration time are short, and dissolution rate is fast, work rapid.

Claims (10)

1. a kind of Oxiracetam oral quick-dissolving film preparation, is obtained according to the following ratio：
Oxiracetam 2-25 parts
Filmogen 40-75 parts
Plasticizer 12-25 parts
Filler 10-35 parts
Sweetener 1-5 parts；
The filmogen is comprising acrylate and at least another macromolecule filming material；Another macromolecule filming material is selected from hydroxypropyl methyl cellulose, hydroxypropyl cellulose, amylopectin, sodium carboxymethylcellulose or pulullan polysaccharide；The plasticizer is selected from the one or more combination in dibutyl phthalate, glyceryl triacetate, triethyl citrate, Trimethyl citrate or PEG400；The filler is selected from the one or more combination in microcrystalline cellulose, low-substituted hydroxypropyl cellulose, pregelatinized starch, Ac-Di-Sol；The sweetener is the one or more combination in acesulfame potassium, sweet Abbas, Sucralose, essence, xylitol；Described part is weight portion.
2. film as claimed in claim 1, it is characterised in that be obtained using following proportioning：
Oxiracetam 5-20 parts
Filmogen 44-62 parts
Plasticizer 10-20 parts
Filler 15-30 parts
Sweetener 1-5 parts；
The filmogen is comprising acrylate and at least another macromolecule filming material；Another macromolecule filming material is selected from hydroxypropyl methyl cellulose, hydroxypropyl cellulose, amylopectin, sodium carboxymethylcellulose, pulullan polysaccharide, and the consumption of wherein hydroxypropyl methyl cellulose, hydroxypropyl cellulose, amylopectin, sodium carboxymethylcellulose or pulullan polysaccharide is respectively：3 parts~35 parts, 8~16 parts, 5~10 parts, 1~5 part, 12~18 parts.
3. film as claimed in claim 1 or 2, it is characterised in that be obtained using following proportioning：
Oxiracetam 8-20 parts
Filmogen 50-62 parts
Plasticizer 10-20 parts
Filler 15-30 parts
Sweetener 1-5 parts；
The filmogen is that acrylate and hydroxypropyl cellulose are constituted, and wherein hydroxypropyl cellulose consumption is 11 parts~15 parts；The filler is low-substituted hydroxypropyl cellulose or pregelatinized starch；The plasticizer is glyceryl triacetate or glyceryl triacetate；The sweetener is acesulfame potassium, sweet Abbas, Sucralose, essence or xylitol.
4. film as claimed in claim 1 or 2, it is characterised in that be obtained using following proportioning：
Oxiracetam 5-15 parts
Filmogen 50-60 parts
Plasticizer 10-20 parts
Filler 10-25 parts
Sweetener 1-5 parts；
The filmogen is that acrylate and hydroxypropyl methyl cellulose are constituted, and wherein HPMC consumption is 5 parts~20 parts；The filler is microcrystalline cellulose or Ac-Di-Sol；The plasticizer is the one kind in glyceryl triacetate or Trimethyl citrate；The sweetener is acesulfame potassium, sweet Abbas, Sucralose, essence or xylitol.
5. the preparation method of Oxiracetam oral quick-dissolving film preparation as claimed in claim 1 or 2, using following steps：
1）By filmogen deionized water dissolving, slough bubble and uniform viscous fluid is obtained；
2）Plasticizer, filler and sweetener deionized water are uniformly dispersed into dispersion liquid；
3）By step 2）Dispersion liquid be added to step 1）Viscous fluid in, and add Oxiracetam to be uniformly dispersed, then stand and slough bubble；
4）Will remove bubble after viscous fluid medicine film coating dryer coating, dry, peel off, cut obtain final product.
6. method as claimed in claim 5, it is characterised in that：The coating speed of the medicine film drying machine is 68-84cm/min, and drying temperature is 72-80 DEG C.
7. method as claimed in claim 5, it is characterised in that：The thickness of obtained Oxiracetam film is 95~110 μm.
8. method as claimed in claim 6, it is characterised in that：The thickness of obtained Oxiracetam film is 95~110 μm.
9. method as claimed in claim 5, it is characterised in that use following steps：
1) by 45-60 parts of filmogen deionized water dissolving, slough bubble and uniform viscous fluid is obtained, the filmogen is that acrylate and hydroxypropyl methyl cellulose are constituted, and wherein HPMC consumption is 10 parts~30 parts；
2）10-18 parts of plasticizer, 15-20 parts of filler and 1-5 parts of sweetener deionized water are uniformly dispersed into dispersion liquid, the plasticizer is dibutyl phthalate, glyceryl triacetate or Trimethyl citrate, the filler is microcrystalline cellulose or low-substituted hydroxypropyl cellulose, and the sweetener is acesulfame potassium, sweet Abbas, Sucralose, essence or xylitol；
3）By step 2）Dispersion liquid be added to step 1）Viscous fluid in, and add 5-20 parts of Oxiracetam to be uniformly dispersed, then stand and slough bubble；
4）The viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 50-80cm/min, then with 65-85 DEG C of drying, stripping, cutting are obtained final product.
10. a kind of preparation method of Oxiracetam film, using following steps：
1) by 44-55 parts of filmogen deionized water dissolving, slough bubble and uniform viscous fluid is obtained, the filmogen is that acrylate and hydroxypropyl cellulose are constituted, and wherein hydroxypropyl cellulose consumption is 11 parts~15 parts；
2）10-15 parts of plasticizer, 15-20 parts of filler and 1-5 part deionized waters are uniformly dispersed into dispersion liquid, the plasticizer is glyceryl triacetate or glyceryl triacetate, the filler is low-substituted hydroxypropyl cellulose or pregelatinized starch, and the sweetener is acesulfame potassium, sweet Abbas, Sucralose, essence or xylitol；
3）By step 2）Dispersion liquid be added to step 1）Viscous fluid in, and add 8-18 parts of Oxiracetam to be uniformly dispersed, then stand and slough bubble；
4）The viscous fluid after bubble will be removed to be coated with medicine film coating dryer, coating speed is 60-80cm/min, then with 70-82 DEG C of drying, stripping, cutting are obtained final product.
CN201510903745.3A 2015-12-07 2015-12-07 A kind of Oxiracetam oral formulations and preparation method thereof Pending CN106822056A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510903745.3A CN106822056A (en) 2015-12-07 2015-12-07 A kind of Oxiracetam oral formulations and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510903745.3A CN106822056A (en) 2015-12-07 2015-12-07 A kind of Oxiracetam oral formulations and preparation method thereof

Publications (1)

Publication Number Publication Date
CN106822056A true CN106822056A (en) 2017-06-13

Family

ID=59152137

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510903745.3A Pending CN106822056A (en) 2015-12-07 2015-12-07 A kind of Oxiracetam oral formulations and preparation method thereof

Country Status (1)

Country Link
CN (1) CN106822056A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090004254A1 (en) * 2007-06-19 2009-01-01 Todd Maibach Film comprising active drugs
CN103083283A (en) * 2013-02-06 2013-05-08 上海现代药物制剂工程研究中心有限公司 Loratadine film preparation
CN103432105A (en) * 2013-09-02 2013-12-11 天津市聚星康华医药科技有限公司 Meclozine oral film and preparation method thereof
CN104940174A (en) * 2015-07-23 2015-09-30 合肥华方医药科技有限公司 Preparation method of donepezil oral fast dissolving film

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090004254A1 (en) * 2007-06-19 2009-01-01 Todd Maibach Film comprising active drugs
CN103083283A (en) * 2013-02-06 2013-05-08 上海现代药物制剂工程研究中心有限公司 Loratadine film preparation
CN103432105A (en) * 2013-09-02 2013-12-11 天津市聚星康华医药科技有限公司 Meclozine oral film and preparation method thereof
CN104940174A (en) * 2015-07-23 2015-09-30 合肥华方医药科技有限公司 Preparation method of donepezil oral fast dissolving film

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
沈淑媛等: "口腔速溶膜剂的研究进展", 《现代药物与临床》 *
赵伟等: "口腔速溶膜剂及其应用", 《天津药学》 *

Similar Documents

Publication Publication Date Title
Samaro et al. Screening of pharmaceutical polymers for extrusion-Based Additive Manufacturing of patient-tailored tablets
JP2020523405A (en) Microneedle transdermal patch containing donepezil
JP2013511565A (en) Film-like pharmaceutical dosage form
CN111447920A (en) Oral film with high active substance loading
Kazsoki et al. Prediction of the hydroxypropyl cellulose—poly (vinyl alcohol) ratio in aqueous solution containing papaverine hydrochloride in terms of drug loaded electrospun fiber formation
TW200848094A (en) Fast disintegration monolayer film for buccal administration of active substances
Karnik et al. Formulation development and characterization of dual drug loaded hot-melt extruded inserts for better ocular therapeutic outcomes: sulfacetamide/prednisolone
CN106822057A (en) A kind of Oxiracetam orodispersible film and preparation method thereof
Nalluri et al. Development and evaluation of mouth dissolving films of salbutamol sulfate
CN103800306B (en) Memantine oral membrane and preparation method thereof
CN106822058A (en) A kind of levo-oxiracetam orodispersible film and preparation method thereof
WO2013023775A1 (en) Orodispersible films for the manufacturing of individualised medicine or for large scale production
CN104940173B (en) Soluble fentanyl, derivative buccal membrane preparation thereof and preparing method thereof
Balaji et al. Formulation and evaluation of mucoadhesive buccal films of atorvastatin using natural protein
CN106821957A (en) A kind of method for preparing levo-oxiracetam orodispersible film
CN106822056A (en) A kind of Oxiracetam oral formulations and preparation method thereof
CN103784426A (en) Aripiprazole oral membrane and preparation method thereof
EP2594257A1 (en) Orodispersible films for the manufacturing of individualised medicine or for large scale production
CN106821960A (en) A kind of preparation method of levo-oxiracetam oral formulations
CN106822053A (en) A kind of levo-oxiracetam oral quick-dissolving film preparation and preparation method thereof
Majidi et al. Development and characterization of sumatriptan-loaded soy bean polysaccharide nanofiber using electrospinning technique
CN106822064A (en) A kind of levo-oxiracetam film and preparation method thereof
CN106822063A (en) A kind of method for preparing Oxiracetam pelliculae pro cavo oris
CN106852916A (en) A kind of method for preparing Oxiracetam oral quick-dissolving film preparation
CN106852918A (en) A kind of Oxiracetam film and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170613